Knowing that deafness, either due to biallelic variants in OTOF or auditory neuropathies/synaptopathies of other etiologies, cannot be reliably diagnosed with OAE screenings, but could be aided with currently available therapies, requires switching newborn hearing screenings to routine ABR testing. This evidence concerns the gene OTOF and deafness.